Teva (Israeli) is the world's largest generic drugmaker.
Teva Pharmaceutical Industries Limited (TEVA) is expected to report earnings on Tuesday, November 3, 2026, before the open. Estimated release time 07:00 ET. Consensus EPS estimate is $0.72.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-29 | Jun 2026 qtr | $0.08 | $0.02 | -75.0% | $4.14B |
| 2026-04-29 | Mar 2026 qtr | $0.50 | $0.53 | +6.0% | $3.98B |
| 2026-01-28 | Dec 2025 qtr | $0.65 | $0.96 | — | $4.71B |
| 2025-11-05 | Sep 2025 qtr | $0.68 | $0.75 | +10.3% | $4.48B |
| 2025-07-30 | Jun 2025 qtr | $0.63 | $0.66 | +4.8% | $4.18B |
| 2025-05-07 | Mar 2025 qtr | $0.47 | $0.52 | +10.6% | $3.89B |
| 2025-01-29 | Dec 2024 qtr | $0.69 | $0.71 | +2.9% | $4.23B |
| 2024-11-06 | Sep 2024 qtr | $0.65 | $0.69 | +6.2% | $4.33B |
TEVA has beaten consensus EPS in 6 of its last 7 scored quarters.
TEVA pays a quarterly dividend, currently yielding 5.80%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2017-11-27 | $0.085 | 2017-12-12 |
| 2017-08-25 | $0.085 | 2017-09-14 |
| 2017-06-01 | $0.34 | 2017-06-22 |
| 2017-02-28 | $0.34 | 2017-03-20 |
| 2016-12-01 | $0.34 | 2016-12-20 |
| 2016-08-18 | $0.34 | 2016-09-08 |